共 50 条
- [32] RESURGENCE OF BLOOD-TRANSFUSION (BT) THERAPY IN ERYTHROPOIETIN (EPO)-TREATED HEMODIALYSIS (HD) PATIENTS JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 455 - 455
- [33] LOW-DOSE DFO TREATMENT (5 MG/KG) IN ACUTELY ALUMINUM-INTOXICATED HEMODIALYSIS (HD) PATIENTS USING 2 DRUG ADMINISTRATION SCHEDULES JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 527 - 527
- [35] Weekly low dose intravenous iron administration decreases the dose of rHuEPO to treat anemia in hemodialysis patients. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A1015 - A1015
- [37] IRON REQUIREMENTS IN PATIENTS ON HEMODIALYSIS (HD) JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 480 - 480
- [38] Helicobacter pylori eradication with a 7-day low-dose triple therapy in hemodialysis patients Clinical and Experimental Nephrology, 2010, 14 : 469 - 473
- [40] LOW-DOSE HUMAN ERYTHROPOIETIN IN CHRONIC-HEMODIALYSIS PATIENTS NEPHRON, 1991, 57 (04): : 483 - 484